好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

No Difference in Statin-Related Reductions in Recurrent Stroke or Other Vascular Events between Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Cerebrovascular Disease and Interventional Neurology
(-)
003
Authors/Disclosures
Larry B. Goldstein, MD, FAHA, FAAN (University of Kentucky) The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Pierre Amarenco, MD Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. The institution of Dr. Amarenco has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. Dr. Amarenco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KOWA company.
No disclosure on file
Joost Raaphorst, MD (Academic Medical Centre) Dr. Raaphorst has nothing to disclose.
No disclosure on file
Marian P. LaMonte, MD, MSN, FAAN (Ascension St. Agnes Hospital) Dr. LaMonte has nothing to disclose.
K. M. Welch, MB, ChB, FRCP (Rosalind Franklin Univ of Medicine And Science) No disclosure on file
No disclosure on file